MAML3 and coronary artery disorder: Rs1869717, located in MAML3 and an enhancer region (ENSR00002016330), was at least nominally associated with DBP (p = 1.83e-02), TC (p = 6.01e-03), HF (p = 1.74e-02), CHD (p = 7.20e-10) and stroke (1.19e-02) in ARIC, stroke (p = 1.01e-02) and death (p = 2.59e-04) in FHS cohort 1, BMI (p = 3.42e-02), SBP (p = 7.35e-04), HDLC (p = 4.70e-03), and FEV1 (p = 9.45e-03) in CHS, BG (p = 2.39e-03) and DM (4.33e-02) in HRS, and TG in FHS cohort 1 and CHS (p = 2.05e-02 and p = 9.66e-03) (Table 3).